JP2019014684A5 - - Google Patents

Download PDF

Info

Publication number
JP2019014684A5
JP2019014684A5 JP2017134071A JP2017134071A JP2019014684A5 JP 2019014684 A5 JP2019014684 A5 JP 2019014684A5 JP 2017134071 A JP2017134071 A JP 2017134071A JP 2017134071 A JP2017134071 A JP 2017134071A JP 2019014684 A5 JP2019014684 A5 JP 2019014684A5
Authority
JP
Japan
Prior art keywords
compound
vnut
group
derivative
inhibitory activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017134071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019014684A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2017134071A priority Critical patent/JP2019014684A/ja
Priority claimed from JP2017134071A external-priority patent/JP2019014684A/ja
Publication of JP2019014684A publication Critical patent/JP2019014684A/ja
Publication of JP2019014684A5 publication Critical patent/JP2019014684A5/ja
Pending legal-status Critical Current

Links

JP2017134071A 2017-07-07 2017-07-07 真菌感染における宿主応答抑制剤 Pending JP2019014684A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017134071A JP2019014684A (ja) 2017-07-07 2017-07-07 真菌感染における宿主応答抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017134071A JP2019014684A (ja) 2017-07-07 2017-07-07 真菌感染における宿主応答抑制剤

Publications (2)

Publication Number Publication Date
JP2019014684A JP2019014684A (ja) 2019-01-31
JP2019014684A5 true JP2019014684A5 (https=) 2020-08-27

Family

ID=65356397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017134071A Pending JP2019014684A (ja) 2017-07-07 2017-07-07 真菌感染における宿主応答抑制剤

Country Status (1)

Country Link
JP (1) JP2019014684A (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121038784A (zh) 2023-04-28 2025-11-28 学校法人久留米大学 三磷酸腺苷分泌抑制剂、肝星状细胞活化抑制剂、肝星状细胞脱活化剂、肝纤维化治疗剂、非酒精性脂肪性肝炎治疗剂、银屑病治疗剂及用于制备三磷酸腺苷分泌抑制剂、肝星状细胞活化抑制剂、肝星状细胞脱活化剂、肝纤维化治疗剂、非酒精性脂肪性肝炎治疗剂及银屑病治疗剂的化合物的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001131073A (ja) * 1999-11-09 2001-05-15 Sumitomo Pharmaceut Co Ltd 疼痛治療剤
US20050152905A1 (en) * 2002-08-22 2005-07-14 Omoigui Osemwota S. Method of biochemical treatment of persistent pain
JPWO2005072746A1 (ja) * 2004-01-30 2007-10-11 アステラス製薬株式会社 Ｐ２ｘ受容体阻害剤
JP5630750B2 (ja) * 2008-03-18 2014-11-26 国立大学法人 岡山大学 興奮性化学伝達調節剤およびそのスクリーニング法

Similar Documents

Publication Publication Date Title
AU2013205648B2 (en) Combination treatment
EP2142192B1 (en) Compositions and kits for treating influenza
JP6091593B2 (ja) 慢性閉塞性肺疾患の急性増悪の治療におけるピラゾール誘導体の使用
JP2014528474A5 (https=)
JP2010535805A5 (https=)
JP2011528355A5 (https=)
IL314873A (en) Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
JP2009528367A (ja) アレナウイルス感染の治療のための抗ウイルス薬剤
JP2015510916A5 (https=)
ES3029560T3 (en) 5-amino-2,3-dihydro-1,4-phthalazinedione as glucocorticoid-sparing agent
RU2013104401A (ru) Фармацевтический препарат, содержащий ингибитор фосфодиэстеразы
JP2018523689A5 (https=)
KR20170125951A (ko) 화학요법에 의해 유도되는 통증의 예방 또는 치료를 위한 시그마 리간드
JP2021522247A (ja) 肝疾患における好中球エラスターゼ阻害薬の使用
JP2008503533A5 (https=)
JP2007518755A (ja) モノアミン神経伝達物質再取り込み阻害剤及びｎ−メチル−ｄ−アスパラギン酸（ｎｍｄａ）受容体アンタゴニストを含む医薬組成物
JP2016516773A5 (https=)
JP2021515769A (ja) カプシド集合調節剤の投薬レジメン
JP2010502736A5 (https=)
AU2016244263A1 (en) Combination ALS therapy
CN102065865A (zh) 多发性骨髓瘤治疗
RU2494736C2 (ru) Комбинация, включающая паклитаксел, для лечения рака яичников
JP2006511538A (ja) 非ヌクレオシド系逆転写酵素阻害剤（ｎｎｒｔｉ）とプロテアーゼ阻害剤などのシトクロムｐ４５０の阻害剤とを含む組み合わせの使用
JP2019507786A5 (https=)
US6498173B1 (en) Synergistic combination comprising roflumilast and a pde-3 inhibitor